Home - Products - Others - Other Targets - 7-Bromoquinazoline-2,4(1H,3H)-Dione

7-Bromoquinazoline-2,4(1H,3H)-Dione

CAS No. 114703-12-7

7-Bromoquinazoline-2,4(1H,3H)-Dione( 7-bromoquinazoline-2,4-diol | 7-Bromo-1H-quinazoline-2,4-dione )

Catalog No. M29556 CAS No. 114703-12-7

7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Bromoquinazoline-2,4(1H,3H)-Dione
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.
  • Description
    7-Bromoquinazoline-2,4(1H,3H)-Dione is a marine derived natural products found in Pyura sacciformis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    7-bromoquinazoline-2,4-diol | 7-Bromo-1H-quinazoline-2,4-dione
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114703-12-7
  • Formula Weight
    241.04
  • Molecular Formula
    C8H5BrN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(=O)C2=CC=C(Br)C=C2N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Oxyresveratrol

    Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gliosis.

  • L-Glutamine

    L-glutamine is a non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes.

  • Zolbetuximab

    Zolbetuximab(IMAB362) is a monoclonal antibody that specifically targets Claudin-18.2.Zolbetuximab has potential antitumor activity, mediating killing of Claudin-18.2-positive cells through an immune effector mechanism.